Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920
Mitchell Machtay, Pedro A. Torres‐Saavedra, Wade L. Thorstad, Phuc Félix Nguyen‐Tan, Lillian L. Siu, F. Christopher Holsinger, Adel K. El‐Naggar, Christine H. Chung, Jennifer A. Dorth, N.Y. Lee, Jason W. Chan, Neal Dunlap, Voichita Bar Ad, William Stokes, Arnab Chakravarti, David J. Sher, Shyam Rao, Jonathan Harris, Sue S. Yom, Quynh‐Thu Le
Topics & Concepts
MedicineCetuximabClinical endpointHead and neck cancerHazard ratioInternal medicineRandomized controlled trialOncologyRadiation therapyExact testHead and neck squamous-cell carcinomaToxicityLog-rank testConfidence intervalCancerSurvival analysisColorectal cancerHead and Neck Cancer StudiesCancer Diagnosis and TreatmentCholangiocarcinoma and Gallbladder Cancer Studies